GNVC TNFerade is still in the Clinical trial stage Phase III PACT Study. the 184th event data results are pending Late March/Early April. The study is not expected to end til the 276 event. For further information on The PACT Study go to the Company website.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.